On April 21-25th 2018, Cloud-Clone Corp exhibited Experimental Biology 2018 (EB 2018).Experimental Biology (EB) is the annual meeting of five societies comprised of more than 14,000 scientists and 25 guest societies.Primary focus areas include anatomy, biochemistry and molecular biology, investigative pathology, pharmacology, and physiology. EB 2018 is open to everyone with interest in the latest research impacting life sciences. Attendees represent scientists from academic institutions, government agencies, non-profit organizations, and industry. This multidisciplinary, scientific meeting features plenary and award lectures, workshops, oral and posters presentations, on-site career se......2018-05-04

On April 16-18th, 2018, the American Cancer Research Association (AACR) hosted the 2018 annual meeting of the American Cancer Research Conference in Chicago. Cloud-Clone and more than 20,000 experts and scholars from more than 50 countries and regions around the world, drug R&D personnel, clinicians and more than 400 enterprises to join together to exchange the research results of advanced cancer drugs for 2018.At the exhibition, Cloud-Clone not only showed researchers the latest technical products in the field of corporate cancer research, such as CRISPR/CAS9 technology platform, KO-validated antibody, CAR-T research and other reagents, as well as communicated with several hundreds of......2018-05-04

MEDLAB held in Dubai, is the largest exhibition of international professional medical equipment in the Middle East, which has the largest exhibition scale and the most complete exhibition category. Since 2002, the exhibition scale has been expanding each year, and the number of exhibitors and the visitors also increasing year by year. As one of the top medical exhibition, MEDLAB attract world’s famous enterprises, and it is well-known in the Middle East Hospital in Arabia countries. 2018 MEDLAB was attended by 25000 participants from the Middle East, Europe, Africa and America. More than 700 exhibitors from more than 70 countries, including SIEMENS and Abbott, etc.Cloud-Clone not onl......2018-02-14

The ASCB/EMBO annual meeting was held on 2-5 December 2017 at the Pennsylvania Conference Center in Philadelphia, United States. As the world's largest ideological exchange and seminar in the world of cell biology, Cloud-Clone, together with 228 other exhibitors, participated in the exhibition. Global well-known biotechnology companies such as Bio-Rad, BD, Biolegend and CST have also participated in this meeting.At the exhibition, Cloud-Clone showed CRO services, KO validation antibodies, Car-T series reagents and other new technology products. It also allows researchers to learn that Cloud-Clone can provide a variety of protein, antibody reagents, and protein, antibodies, and kit ......2017-12-28

On November 11-15th, 2017, Cloud-Clone Corp. attended the 2017 Annual Meeting of Society of Neuroscience at the Walter E. Washington Convention Center in Washington, D.C. The meeting attracted total 517 neuroscience-related companies and organizations, and more than 30,021 attendees including scientists and managers from world-wide. During the meeting, Cloud-Clone Corp. introduced its featured products and services, including proteins, antibodies, assay kits, animal disease model and custom service to the visitors in the field of neuroscience research.2017-12-08

Conference introductionJune 29th-July 3rd2017, American Chinese Biological Science Conference, also called Society of Chinese Bioscientists in America the 16th International Symposium, referred to as: 2017 SCBA was held in Hangzhou, 5 days total. About 1400 delegates attended the conference, including about 300 overseas delegates. Many biologists were invited, including Pro. Shi Yigong from Tsinghua University, Pro. Hans Clevers from Hubrecht Institute, Pro. Melanie Cobb from University of Texas Southwestern Medical Center and Pro. Weissman Irving from Stanford, all made great academic reports.The theme of this conference is "Advancing Science, Improving, Health". It aims to ......2017-07-11